$MDRX
Veradigm Inc.

2013 Q4 Form 10-Q Financial Statement

#000119312513438216 Filed on November 12, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $351.0M $330.2M $360.7M
YoY Change -0.01% -8.46% -0.84%
Cost Of Revenue $212.8M $204.6M $203.7M
YoY Change -0.85% 0.48% 0.94%
Gross Profit $138.2M $125.5M $157.0M
YoY Change 1.39% -20.05% -3.05%
Gross Profit Margin 39.38% 38.02% 43.54%
Selling, General & Admin $109.3M $104.5M $90.41M
YoY Change 4.67% 15.59% -1.89%
% of Gross Profit 79.07% 83.24% 57.57%
Research & Development $47.87M $49.40M $37.80M
YoY Change -4.26% 30.68% 45.21%
% of Gross Profit 34.64% 39.35% 24.07%
Depreciation & Amortization $47.00M $46.80M $37.70M
YoY Change 18.69% 24.14% 12.54%
% of Gross Profit 34.01% 37.28% 24.01%
Operating Expenses $157.1M $153.9M $128.2M
YoY Change -3.59% 20.04% 8.49%
Operating Profit -$27.55M -$43.45M $9.184M
YoY Change 3.16% -573.13% -73.28%
Interest Expense $7.024M $6.895M $3.718M
YoY Change -263.35% 85.45% -0.75%
% of Operating Profit 40.48%
Other Income/Expense, Net -$213.0K -$826.0K -$15.85M
YoY Change -126.63% -94.79% -4061.25%
Pretax Income -$34.78M -$51.17M -$10.38M
YoY Change 15.55% 393.04% -133.43%
Income Tax -$14.16M -$2.233M -$19.75M
% Of Pretax Income
Net Earnings -$20.62M -$48.94M $9.375M
YoY Change -15.15% -622.03% -51.01%
Net Earnings / Revenue -5.87% -14.82% 2.6%
Basic Earnings Per Share -$0.27 $0.05
Diluted Earnings Per Share -$115.3K -$0.27 $0.05
COMMON SHARES
Basic Shares Outstanding 178.5M shares 178.2M shares 170.9M shares
Diluted Shares Outstanding 178.2M shares 172.8M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $63.00M $60.80M $93.70M
YoY Change -39.42% -35.11% 10.5%
Cash & Equivalents $62.95M $60.79M $93.67M
Short-Term Investments
Other Short-Term Assets $163.4M $172.6M $165.1M
YoY Change -1.86% 4.54% 21.94%
Inventory $1.722M
Prepaid Expenses
Receivables $313.5M $322.3M $371.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $539.8M $555.7M $631.8M
YoY Change -5.72% -12.05% 6.49%
LONG-TERM ASSETS
Property, Plant & Equipment $174.0M $166.6M $143.8M
YoY Change 11.91% 15.82% 39.77%
Goodwill $1.190B $1.190B $1.039B
YoY Change 14.45% 14.45%
Intangibles $508.0M $523.8M $494.4M
YoY Change 6.05% 5.94%
Long-Term Investments $1.300M $1.400M $1.700M
YoY Change -23.53% -17.65% 0.0%
Other Assets $163.3M $156.7M $38.03M
YoY Change 224.71% 311.97% -58.57%
Total Long-Term Assets $2.080B $2.083B $1.776B
YoY Change 17.04% 17.28% -3.13%
TOTAL ASSETS
Total Short-Term Assets $539.8M $555.7M $631.8M
Total Long-Term Assets $2.080B $2.083B $1.776B
Total Assets $2.620B $2.638B $2.408B
YoY Change 11.5% 9.59% -0.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.96M $51.00M $51.77M
YoY Change 59.04% -1.49% 34.45%
Accrued Expenses $96.50M $92.39M $85.42M
YoY Change 3.65% 8.16% -28.34%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $16.40M $13.60M $72.29M
YoY Change -79.18% -81.19% 77.61%
Total Short-Term Liabilities $517.0M $520.1M $540.4M
YoY Change -0.21% -3.76% 16.68%
LONG-TERM LIABILITIES
Long-Term Debt $545.1M $530.5M $386.8M
YoY Change 50.3% 37.17% 14.57%
Other Long-Term Liabilities $130.6M $135.7M $38.29M
YoY Change 237.33% 254.28% -51.53%
Total Long-Term Liabilities $675.7M $666.2M $425.1M
YoY Change 68.34% 56.72% 2.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $517.0M $520.1M $540.4M
Total Long-Term Liabilities $675.7M $666.2M $425.1M
Total Liabilities $1.302B $1.307B $1.109B
YoY Change 22.19% 17.94% 12.24%
SHAREHOLDERS EQUITY
Retained Earnings -$121.6M -$100.9M $6.792M
YoY Change 593.42% -1586.13%
Common Stock $2.635M $2.631M $2.561M
YoY Change 2.49% 2.73%
Preferred Stock
YoY Change
Treasury Stock (at cost) $278.0M $278.0M $278.0M
YoY Change 0.0% 0.0%
Treasury Stock Shares $84.67M 84.67M shares 84.67M shares
Shareholders Equity $1.318B $1.331B $1.299B
YoY Change
Total Liabilities & Shareholders Equity $2.620B $2.638B $2.408B
YoY Change 11.5% 9.59% -0.78%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$20.62M -$48.94M $9.375M
YoY Change -15.15% -622.03% -51.01%
Depreciation, Depletion And Amortization $47.00M $46.80M $37.70M
YoY Change 18.69% 24.14% 12.54%
Cash From Operating Activities $17.70M $12.50M $31.10M
YoY Change -69.59% -59.81% -26.3%
INVESTING ACTIVITIES
Capital Expenditures -$28.70M -$22.30M -$29.10M
YoY Change 1.41% -23.37% 2.83%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $100.0K
YoY Change -100.0%
Cash From Investing Activities -$28.60M -$22.30M -$29.10M
YoY Change 1.06% -23.37% 2.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.20M -1.600M -29.60M
YoY Change -168.04% -94.59% -31.16%
NET CHANGE
Cash From Operating Activities 17.70M 12.50M 31.10M
Cash From Investing Activities -28.60M -22.30M -29.10M
Cash From Financing Activities 13.20M -1.600M -29.60M
Net Change In Cash 2.300M -11.40M -27.60M
YoY Change -78.1% -58.7% -5.48%
FREE CASH FLOW
Cash From Operating Activities $17.70M $12.50M $31.10M
Capital Expenditures -$28.70M -$22.30M -$29.10M
Free Cash Flow $46.40M $34.80M $60.20M
YoY Change -46.36% -42.19% -14.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 mdrx Stock Repurchase Program Authorized Repurchase Amount
StockRepurchaseProgramAuthorizedRepurchaseAmount
400000000
CY2012Q2 mdrx Damages Sought Per Violation
DamagesSoughtPerViolation
500
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
178456017 shares
CY2011Q2 mdrx Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2014-05-09
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93672000
CY2013Q1 us-gaap Escrow Deposit
EscrowDeposit
2000000
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
263074000 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q3 us-gaap Derivative Variable Interest Rate
DerivativeVariableInterestRate
0.0243 pure
CY2013Q3 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.00896 pure
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
349000000 shares
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
84672000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11000
us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
0
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
178402000 shares
CY2013Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
28274000
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
50625000
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
520147000
CY2013Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1200000
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1115000
CY2013Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
21000000
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
59087000
CY2013Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
530545000
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1708492000
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
50995000
CY2013Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16300000
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
135668000
CY2013Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
13624000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
1331034000
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
16875000
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-100938000
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
304055000
CY2013Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
627188000
CY2013Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
345000000
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
92386000
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
39375000
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
55787000
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
144375000
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
28125000
CY2013Q3 us-gaap Long Term Debt
LongTermDebt
543609000
CY2013Q3 us-gaap Liabilities
Liabilities
1307380000
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2813000
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
568407000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
2631000
CY2013Q3 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
-700000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2638414000
CY2013Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
92746000
CY2013Q3 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
1794000
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
156673000
CY2013Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1373000
CY2013Q3 us-gaap Goodwill
Goodwill
1189585000
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
471758000
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
322342000
CY2013Q3 us-gaap Goodwill Gross
GoodwillGross
1039364000
CY2013Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
55508000
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
278036000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
166579000
CY2013Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7529000
CY2013Q3 us-gaap Assets
Assets
2638414000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60790000
CY2013Q3 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
52000000
CY2013Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
89226000
CY2013Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
419758000
CY2013Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
83579000
CY2013Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
988165000
CY2013Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1241585000
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
117051000
CY2013Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
12100000
CY2013Q3 us-gaap Assets Current
AssetsCurrent
555691000
CY2013Q3 mdrx Preferred Stock Shares Issued And Outstanding
PreferredStockSharesIssuedAndOutstanding
0 shares
CY2013Q3 mdrx Foreign Subsidiary Capital Stock
ForeignSubsidiaryCapitalStock
0.65 pure
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
157753000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
257087000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
349000000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
84672000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
172415000 shares
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
19750000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
545574000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
76000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
18100000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
44124000
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
362697000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1577260000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
45874000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
38707000
CY2012Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
79305000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
1284341000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17530000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
310326000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
283171000
CY2012Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
441467000
CY2012Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
93100000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45320000
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
441467000
CY2012Q4 us-gaap Liabilities
Liabilities
1092641000
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
521029000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2571000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2376982000
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
125913000
CY2012Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
14825000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
50304000
CY2012Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1706000
CY2012Q4 us-gaap Goodwill
Goodwill
1039364000
CY2012Q4 us-gaap Cost Method Investments
CostMethodInvestments
13000000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
426986000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
329542000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
56499000
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
278036000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
155494000
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7529000
CY2012Q4 us-gaap Assets
Assets
2376982000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103956000
CY2012Q4 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
52000000
CY2012Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
95579000
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
374986000
CY2012Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
896015000
CY2012Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1091364000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
110023000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
600020000
CY2012Q4 mdrx Preferred Stock Shares Issued And Outstanding
PreferredStockSharesIssuedAndOutstanding
0 shares
dei Trading Symbol
TradingSymbol
MDRX
dei Entity Registrant Name
EntityRegistrantName
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001124804
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2020-07-01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0084 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176517000 shares
us-gaap Loss Contingency Allegations
LossContingencyAllegations
Counterclaims against Pegasus for breach of two license agreements, breach of warranty, breach of a settlement and arbitration agreement, and three counts of negligent misrepresentation
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.266 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
2900000
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
564000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0225 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
63311000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2200000 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11388000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of Estimates</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates.</font></p> </div>
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.63
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
176517000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.5491 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
6240000 shares
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
29671000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
56988000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
30462000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-83408000
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
0
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7884000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
856000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
85978000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-113564000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1724000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10966000
us-gaap Maintenance Revenue
MaintenanceRevenue
351840000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
148875000
us-gaap Costmethod Investments Realized Gain Loss Excluding Other Than Temporary Impairments
CostmethodInvestmentsRealizedGainLossExcludingOtherThanTemporaryImpairments
4700000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
574281000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
31537000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7523000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
3296000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-83408000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
169293000
us-gaap Revenues
Revenues
1022084000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
25330000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-84599000
us-gaap Gross Profit
GrossProfit
396257000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2660000
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
us-gaap Operating Income Loss
OperatingIncomeLoss
-100056000
us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
123000000
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
82800000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
522000
us-gaap Net Income Loss
NetIncomeLoss
-83408000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
416000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1191000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-112000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
625827000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
153647000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
12313000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
118653000
us-gaap Maintenance Costs
MaintenanceCosts
107864000
us-gaap Cost Of Services
CostOfServices
162278000
us-gaap Share Based Compensation
ShareBasedCompensation
28594000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
41176000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-43166000
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
3901000
us-gaap Interest Expense Debt
InterestExpenseDebt
10918000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3055000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-30156000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1660000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-968000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
23169000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8981000
us-gaap Interest Expense
InterestExpense
21031000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8707000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11256000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-3426000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-8466000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
410983000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
10504000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
131797000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
334000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3157000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
336962000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3296000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27788000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-223470000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
51208000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
151881000
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
12855000
mdrx Transaction Processing And Other
TransactionProcessingAndOther
414973000
mdrx Stock Granted During Period Value And Other
StockGrantedDuringPeriodValueAndOther
0
CY2012Q3 us-gaap Income Tax Reconciliation Tax Settlements
IncomeTaxReconciliationTaxSettlements
16000000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4352000
mdrx Reinstatement Of Tax Credit Included In Tax Benefit
ReinstatementOfTaxCreditIncludedInTaxBenefit
2900000
mdrx Stockholders Rights Plan Date Of Record
StockholdersRightsPlanDateOfRecord
2012-05-17
mdrx Transaction Processing And Other Cost
TransactionProcessingAndOtherCost
251973000
mdrx Gain Loss On Change In Fair Value Of Convertible Notes
GainLossOnChangeInFairValueOfConvertibleNotes
-939000
mdrx Debt Instrument Settlement
DebtInstrumentSettlement
31600000
mdrx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExercisePrice
13.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
182991000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1835000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.833 pure
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
303000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
164548000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
20700000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1182000 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.13
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
181156000 shares
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55481000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
39340000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
79000
us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
6317000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
116176000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
23169000
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
0
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
233259000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-951000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15303000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
609000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
23169000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
201615000
CY2013Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2732000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3098000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-103000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
-168000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12638000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
429000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8094000
us-gaap Maintenance Revenue
MaintenanceRevenue
354295000
us-gaap Revenues
Revenues
1095362000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23574000
us-gaap Gross Profit
GrossProfit
470203000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-795000
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
us-gaap Operating Income Loss
OperatingIncomeLoss
39871000
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
0
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
225961000
us-gaap Net Income Loss
NetIncomeLoss
23169000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
635000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
405000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-1544000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
625159000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1628000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-135521000
us-gaap Maintenance Costs
MaintenanceCosts
108850000
us-gaap Cost Of Services
CostOfServices
173260000
us-gaap Share Based Compensation
ShareBasedCompensation
26463000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
49342000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
226000000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-64081000
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0
us-gaap Interest Expense Debt
InterestExpenseDebt
8125000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
280020000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10531000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1629000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-1376000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
14379000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-17916000
us-gaap Interest Expense
InterestExpense
11930000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7767000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4042000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
686000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
324035000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
11101000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
110582000
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
104506000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
-65000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3805000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
609000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26463000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-94737000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
112164000
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
84000
mdrx Transaction Processing And Other
TransactionProcessingAndOther
423276000
mdrx Transaction Processing And Other Cost
TransactionProcessingAndOtherCost
246441000
mdrx Gain Loss On Change In Fair Value Of Convertible Notes
GainLossOnChangeInFairValueOfConvertibleNotes
0
CY2012Q2 mdrx Stock Repurchase Program Additional Stock Repurchased Authorized Amount
StockRepurchaseProgramAdditionalStockRepurchasedAuthorizedAmount
200000000
CY2011Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2011Q2 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
200000000
CY2010Q4 mdrx Interest Rate Swap Agreements Effective Date
InterestRateSwapAgreementsEffectiveDate
2010-10-29
CY2010Q4 mdrx Interest Rate Swap Agreement Termination Date
InterestRateSwapAgreementTerminationDate
2014-10-31
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2400000 shares
CY2012 mdrx Impairment Of Indemnification Assets
ImpairmentOfIndemnificationAssets
16000000
CY2012 mdrx Amount Reclassified From Deferred Revenue To Account Receivable Allowance
AmountReclassifiedFromDeferredRevenueToAccountReceivableAllowance
7500000
CY2013Q1 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
12500000
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172754000 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1880000 shares
CY2012Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.903 pure
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2340000 shares
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.05
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170874000 shares
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
75000
CY2012Q3 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
0
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
35220000
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9375000
CY2012Q3 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
0
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15845000
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
9375000
CY2012Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
62749000
CY2012Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
-1000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10379000
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
556000
CY2012Q3 us-gaap Maintenance Revenue
MaintenanceRevenue
119263000
CY2012Q3 us-gaap Revenues
Revenues
360694000
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10004000
CY2012Q3 us-gaap Gross Profit
GrossProfit
157036000
CY2012Q3 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9184000
CY2012Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-2000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
9375000
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
629000
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-433000
CY2012Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
203658000
CY2012Q3 us-gaap Maintenance Costs
MaintenanceCosts
36564000
CY2012Q3 us-gaap Cost Of Services
CostOfServices
54534000
CY2012Q3 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
13582000
CY2012Q3 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0
CY2012Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
2432000
CY2012Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
90412000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19754000
CY2012Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-432000
CY2012Q3 us-gaap Interest Expense
InterestExpense
3718000
CY2012Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
11101000
CY2012Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
1000
CY2012Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1286000
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8807000
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37802000
CY2012Q3 mdrx Transaction Processing And Other
TransactionProcessingAndOther
143462000
CY2012Q3 mdrx Transaction Processing And Other Cost
TransactionProcessingAndOtherCost
82600000
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0138 pure
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
178166000 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2013Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.044 pure
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2233000
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24839000 shares
CY2013Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-286000
CY2013Q3 us-gaap Interest Expense
InterestExpense
6895000
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.50
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
178166000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.4799 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
302000 shares
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
27000
CY2013Q3 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
0
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
26498000
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-48940000
CY2013Q3 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
0
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-826000
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-48940000
CY2013Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
49003000
CY2013Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
207000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-51173000
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
725000
CY2013Q3 us-gaap Maintenance Revenue
MaintenanceRevenue
117928000
CY2013Q3 us-gaap Revenues
Revenues
330191000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48063000
CY2013Q3 us-gaap Gross Profit
GrossProfit
125547000
CY2013Q3 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-43452000
CY2013Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
125000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-48940000
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
877000
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-79000
CY2013Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
204644000
CY2013Q3 us-gaap Maintenance Costs
MaintenanceCosts
35841000
CY2013Q3 us-gaap Cost Of Services
CostOfServices
47295000
CY2013Q3 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
14767000
CY2013Q3 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0
CY2013Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
7371000
CY2013Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
82000
CY2013Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
3653000
CY2013Q3 mdrx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExercisePrice
15.22
CY2013Q3 mdrx Transaction Processing And Other Cost
TransactionProcessingAndOtherCost
83735000
CY2013Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
510000
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9678000
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49400000
CY2013Q3 mdrx Transaction Processing And Other
TransactionProcessingAndOther
136762000

Files In Submission

Name View Source Status
0001193125-13-438216-index-headers.html Edgar Link pending
0001193125-13-438216-index.html Edgar Link pending
0001193125-13-438216.txt Edgar Link pending
0001193125-13-438216-xbrl.zip Edgar Link pending
d596792d10q.htm Edgar Link pending
d596792dex101.htm Edgar Link pending
d596792dex311.htm Edgar Link pending
d596792dex312.htm Edgar Link pending
d596792dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mdrx-20130930.xml Edgar Link completed
mdrx-20130930.xsd Edgar Link pending
mdrx-20130930_cal.xml Edgar Link unprocessable
mdrx-20130930_def.xml Edgar Link unprocessable
mdrx-20130930_lab.xml Edgar Link unprocessable
mdrx-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending